title: Successful treatment of azole-resistant Candida spondylodiscitis with high-dose caspofungin monotherapy.
authors: Theodoros
authors: T
authors: Kelesidis
authors: Kelesidis
authors: K
authors: Theodoros
authors: Sotirios
authors: S
authors: Tsiodras
authors: Tsiodras
authors: T
authors: Sotirios
mesh_terms: D000328:Adult; D000935:Antifungal Agents / Q000627:therapeutic use; D001393:Azoles / Q000627:therapeutic use*; D002176:Candida albicans / Q000302:isolation & purification; D002177:Candidiasis / Q000150:complications / Q000188:drug therapy*; D000077336:Caspofungin; D015299:Discitis / Q000188:drug therapy* / Q000382:microbiology; D004305:Dose-Response Relationship, Drug; D025141:Drug Resistance, Fungal; D054714:Echinocandins / Q000627:therapeutic use*; D015658:HIV Infections / Q000150:complications / Q000276:immunology; D006801:Humans; D016867:Immunocompromised Host; D055666:Lipopeptides; D008297:Male; D013904:Thoracic Vertebrae / Q000382:microbiology*; D016896:Treatment Outcome
chemical_list: D000935:Antifungal Agents; D001393:Azoles; D054714:Echinocandins; D055666:Lipopeptides; D000077336:Caspofungin